Amneal Pharmaceuticals Inc

AMRXNASDAQ · USD
21.38USD0.00 (-1.48%)
3910

Amneal Pharmaceuticals Inc (AMRX) Covered Calls

Amneal Pharmaceuticals Inc trades in the Drug Manufacturers - Specialty & Generic industry with an IV Rank of 24.60%, low versus the past year. AMRX's highest covered call setup is the $25.00 strike expiring Mar 19, 2027, sorted by theoretical annualized return. It's 16.93% out of the money with 126 days to expiration, a 17.40% return until expiration, and a 50.40% theoretical annualized return. Across the setups shown, annualized returns run from 15.57% to 50.40% at strikes between $22.50 and $25.00, with 126 to 216 days to expiration, as of Nov 13, 2026.

Read more

Running AMRX covered calls helps you generate income from Amneal Pharmaceuticals Inc shares you already own, turning a long stock position into a yield producing asset. A covered call means holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike. Use our scanner to find the best AMRX covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.

A covered call pairs limited risk with a clear income profile. If AMRX stays below the strike at expiration, you keep the premium and the shares. If it rises above, you deliver the stock at the strike and still pocket the premium. Selling AMRX covered calls works best when implied volatility is elevated, since richer premiums improve the risk reward. Key inputs include strike selection relative to delta, days to expiration, annualized return, and probability of assignment, all of which determine whether a given AMRX covered call is worth writing.

Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals across a range of therapeutic categories. The Specialty segment is involved in the development, promotion, distribution, and sale of branded pharmaceutical products with focus on central nervous system disorders, endocrinology, parasitic infections, and other therapeutic areas.

2027-03-1912625.0016.930.102.00372.0017.4050.40-0.47+0.332081.90
2027-03-1912622.505.240.204.40132.006.1717.88-0.94+0.51194.20
2027-06-1721622.505.240.854.90197.009.2115.57-3.98+0.5424.05

As of Nov 13, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →

Stock Statistics

  • IndustryDrug Manufacturers - Specialty & Generic
  • SectorHealthcare
  • IV Rank24.60% Low
  • Market cap (M$)7,449
  • 52 weeks high-3.13%
  • 52 weeks low87.71%
  • Analyst recommendationStrong Buy
    1.12
  • Target price$24.29
    13.61% above the current stock price
  • Dividend—
  • Payout ratio0.00%
  • Earnings date2026-11-03
  • P/E52.49
  • Future P/E17.34
  • EPS (ttm)0.41
  • EPS growth next 5 years21.09%

As of Nov 13, 2026